Tissue transplantation

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS107
Academic Journal
Presents an abstract of the research manuscript `Does long-term triple therapy improve cadaveric renal graft survival?,' by M.A. Baltzan et al. Triple treatment of cyclosporine, azathioprine and steroid.


Related Articles

  • 372. Steroid-free regimen does not impact graft survival. Matas, A.J.; Ramcharan, T.; Paraskevas, S. // Kidney;May/Jun2002, Vol. 11 Issue 3, p123 

    Focuses on a study which examined the rapid discontinuation of steroids in living donor kidney transplantation. Methodology; Results; Conclusion.

  • Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience. Gheith, Osama A.; Bakr, Mohamed A.; Fouda, Mohamed A.; Shokeir, Ahmed A.; Sobh, Mohamed; Ghoneim, Mohamed // Clinical & Experimental Nephrology;Jun2007, Vol. 11 Issue 2, p151 

    The achievements in short-term graft survival since the introduction of cyclosporine (CsA) have not been matched by improvements in long-term graft function. Chronic allograft nephropathy (CAN) remains the second most common cause of graft attrition over time, after patient mortality. We aimed...

  • Three-Year Outcomes in Kidney Transplant Patients Randomized to Steroid-Free Immunosuppression or Steroid Withdrawal, with Enteric-Coated Mycophenolate Sodium and Cyclosporine: The Infinity Study. Thierry, A.; Mourad, G.; Büchler, M.; Choukroun, G.; Toupance, O.; Kamar, N.; Villemain, F.; Le Meur, Y.; Legendre, C.; Merville, P.; Kessler, M.; Heng, A.-E.; Moulin, B.; Queré, S.; Di Giambattista, F.; Lecuyer, A.; Touchard, G. // Journal of Transplantation;2014, p1 

    In a six-month, multicenter, open-label trial, de novo kidney transplant recipients at low immunological risk were randomized to steroid avoidance or steroid withdrawal with IL-2 receptor antibody (IL-2RA) induction, enteric-coated mycophenolate sodium (EC-MPS: 2160mg/day to week 6,1440mg/day...

  • Renal transplantation with early steroid withdrawal. Schiff, Jeffrey; Cole, Edward // Pediatric Nephrology;Feb2009, Vol. 24 Issue 2, p243 

    Steroids are effective immunosuppressants in renal transplantation but are associated with significant adverse effects. As a result, there has been increased interest in protocols utilizing steroid minimization. Initial trials stopped steroids at approximately 3 months, when the highest risk...

  • Efikasnost terapijskog monitoringa ciklosporina odreÄ‘ivanjem C2 i PIK0-4 tokom prva 24 meseca posle transplantacije bubrega. Vavić, Neven; Ignjatović, Ljiljana; Drašković, Biljana; Hrvačević, Rajko; Kovačević, Zoran; Paunić, Zoran // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Feb2008, Vol. 65 Issue 2, p119 

    Background/Aim. Cyclosporine (CyA) therapeutic drug monitoring (TDM) through the measurement of drug concentration in blood two hours after the administration (C2), and/or according to the calculated value of the area under the concentration -- time curve during the first four hours following...

  • Subtherapeutic Levels More Common with Conventional CsA.  // Kidney;Mar/Apr99, Vol. 8 Issue 2, p75 

    Presents an abstract of the study 'Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients,' by U.A. Frei, H.-H. Heumayer, B. Bucholz, et al.

  • Renal Allograft Biopsies Vital to Clinical Management.  // Kidney;Nov/Dec99, Vol. 8 Issue 6, p260 

    Evaluates the usefulness of the allograft biopsy in renal transplant (RT) recipients receiving cyclosporine (CyA). Change in patient management in 42 percent of the patients according to biopsy findings; Similarity of response to therapy to those of patients whose management plan had not been...

  • Transplantation.  // Kidney;Jan/Feb2000, Vol. 9 Issue 1, p31 

    Presents summaries of studies on kidney transplantation. 'Cyclosporine-Associated Thrombotic Microangiopathy in Renal Allografts,' by A. Zarifian, S. Meleg-Smith, R. O'Donovan et al; 'Hepatitis C Virus Genotype Does Not Affect Patient Survival Among Renal Transplant Candidates,' by S.V. Natov,...

  • CsA Monotherapy 6-12 Months Post- Transplant of VAlue in Low-Risk Patients.  // Kidney;May/Jun98, Vol. 7 Issue 3, p123 

    Discusses the abstract of the research paper 'Maintenance cyclosporin monotherapy after renal transplantation--Clinical predictors of long-term outcome,' by G. Touchard, T. Hauet et al and published in a 1997 issue of 'Nephrology, Dialysis and Transplantation.'


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics